Portfolio Company Headlines

September 20, 2016

Santa Rosa, CA
Claret Medical Announces SENTINEL Pivotal IDE Trial to Be Featured in Late-Breaking Trial Session at Transcatheter Cardiovascular Therapeutics (TCT) Conference

May 4, 2016

Goleta, CA
BAROnova Announces Appointment of David S. Thrower as President and Chief Executive Officer

April 7, 2016

Austin, TX
Lumos Pharma Raises $34 Million in Series B Financing

January 28, 2016

Santa Rosa, CA
Millipede’s Play In Percutaneous Mitral Valve Repair

January 11, 2016

Seattle, WA
Juno Therapeutics Adds Next-Generation Single Cell Sequencing Capabilities Through Acquisition of AbVitro

December 22, 2015

Santa Rosa, CA
Cerebral Embolic Protection For TAVR: Start-Ups Compete

December 11, 2015

Goleta, CA
BAROnova Announces Enrollment of First Patients in the ENDObesity II Pivotal Clinical Trial

November 23, 2015

Goleta, CA
BAROnova Closes $36.5 Million Series D Financing

October 20, 2015

St. Louis, MO
EndoStim receives CE Mark for full body MRI use with EndoStim II LES Stimulation System

October 13, 2015

St. Louis, MO
EndoStim’s neurostimulation therapy for GERD receives permanent reimbursement coverage in Germany

October 6, 2015

Austin, TX
Baxter, Boston back TVA in $15M Round to Ease Hemodialysis Vascular Access

April 30, 2015

Austin, TX
Mirna Therapeutics Secures $41.8 Million Series D Financing to Advance Oncology microRNA Pipeline

April 14, 2015

Cleveland, OH
IBM Acquires Explorys to Accelerate Cognitive Insights for Health and Wellness

February 26, 2015

San Francisco, CA
Lyric Pharmaceuticals Announces $20.4M Series A Funding Round

February 18, 2015

La Jolla, CA
Laguna Pharmaceuticals Completes $30 Million Series B Financing, Appoints Industry Veteran Bob Baltera as CEO